Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Cohen

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
The Oncologist|November 10, 2009
Circulating tumor cells: evolving evidence and future challengesEfrat Dotan, Steven J Cohen, Katherine R Alpaugh, et al.
Journal of Surgical Oncology|October 3, 2015
Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancerTalha Shaikh, Alan Thomay, Karen Ruth, et al.
Cureus|October 26, 2022
Trends in Palliative Care, Hospice Utilization, and Outcomes in Hospitalized Pancreatic Cancer Patients: A Nationwide AnalysisKuldeepsinh P Atodaria, Steven J Cohen, Samyak Dhruv, et al.
Clinical Colorectal Cancer|August 16, 2005
Changing patterns of bone and brain metastases in patients with colorectal cancerMark L Sundermeyer, Neal J Meropol, Andre Rogatko, et al.
Cancer|July 6, 2016
Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancerNamrata Vijayvergia, Tianyu Li, Yu-Ning Wong, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2018
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancerRobert J Mayer, Howard S Hochster, Steven J Cohen, et al.
Journal of the National Cancer Institute|January 1, 2016
Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal CancerJoshua E Meyer, Steven J Cohen, Karen J Ruth, et al.
Science Signaling|December 13, 2012
Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling"Barbara Burtness, Shanthi Marur, Julie E Bauman, et al.
Journal of Geriatric Oncology|January 10, 2020
Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy eraRishi Jain, Namrata Vijayvergia, Karthik Devarajan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Successful imatinib therapy for neuroendocrine carcinoma with activating Kit mutation: a case studyJames Perkins, Patrick Boland, Steven J Cohen, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
The Oncologist|November 10, 2009
Circulating tumor cells: evolving evidence and future challengesEfrat Dotan, Steven J Cohen, Katherine R Alpaugh, et al.
Journal of Surgical Oncology|October 3, 2015
Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancerTalha Shaikh, Alan Thomay, Karen Ruth, et al.
Cureus|October 26, 2022
Trends in Palliative Care, Hospice Utilization, and Outcomes in Hospitalized Pancreatic Cancer Patients: A Nationwide AnalysisKuldeepsinh P Atodaria, Steven J Cohen, Samyak Dhruv, et al.
Clinical Colorectal Cancer|August 16, 2005
Changing patterns of bone and brain metastases in patients with colorectal cancerMark L Sundermeyer, Neal J Meropol, Andre Rogatko, et al.
Cancer|July 6, 2016
Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancerNamrata Vijayvergia, Tianyu Li, Yu-Ning Wong, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2018
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancerRobert J Mayer, Howard S Hochster, Steven J Cohen, et al.
Journal of the National Cancer Institute|January 1, 2016
Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal CancerJoshua E Meyer, Steven J Cohen, Karen J Ruth, et al.
Science Signaling|December 13, 2012
Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling"Barbara Burtness, Shanthi Marur, Julie E Bauman, et al.
Journal of Geriatric Oncology|January 10, 2020
Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy eraRishi Jain, Namrata Vijayvergia, Karthik Devarajan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Successful imatinib therapy for neuroendocrine carcinoma with activating Kit mutation: a case studyJames Perkins, Patrick Boland, Steven J Cohen, et al.
Pageof 11